Robinson Cole LLP
High Contrast Mode

Michael J. Kearney, Jr. represents clients in connection with a wide range of tax matters. He is an experienced tax lawyer with a broad-based transactional tax practice involving corporations, partnerships, and LLCs. His experience includes advising clients on domestic and cross-border mergers and acquisitions, buyouts, and joint ventures, private equity fund structuring, formation, and investment, real estate taxation, and restructurings and workouts. 

Tax

Mike advises clients on federal and international tax matters. He works closely with clients including multinational corporations and private equity funds on domestic and cross-border mergers and acquisitions, joint ventures, U.S. tax withholding and reporting obligations, expatriations, and tax treaties. His experience also includes managing tax structuring and due diligence teams. He is a member of the International Fiscal Association, USA Branch (Westchester County, NY/Connecticut Region).

Private Investment Funds

Mike has represented middle market private equity fund sponsors and investors (U.S. taxable, tax-exempt and non-U.S. taxpayers) on tax matters associated with fund structure (domestic and offshore), formation, operations, co-investments, and secondary transactions. He also represents non-U.S. resident investors on strategic tax planning and structuring related to U.S. investments.

  • New York University School of Law (Juris Masters)
    • LL.M., Taxation
  • Catholic University of America, Columbus School of Law (Juris Doctor)
  • Villanova University (Bachelors)
    • Finance

  • State of Connecticut
  • State of New York
  • District of Columbia
  • U.S. Tax Court

Presented with the 2024 U.S.A. Deal of the Year award, in the small markets category, as part of the Global M&A Network's 15th Annual Americas and Global Markets M&A Atlas Awards in recognition of the acquisition of Medacist Solutions Group by Bluesight, the Medication Intelligence™ Company.

IFA USA Westchester-Connecticut 
Co-Regional Vice President 

International Fiscal Association, U.S.A. Branch
Westchester County, NY/Connecticut Region

Experience


Represented Help at Home in Acquisition of Home Care Now of Central Florida

Represented Help at Home, a nationwide leading provider of innovative, relationship-driven, in-home personal care, in its acquisition of Home Care Now of Central Florida, a state-licensed home care agency providing personalized home health services in central Florida. The acquisition will see Help at Home expand and strengthen its Florida presence to provide home care services across every county throughout the state.

Read More
Represented Help at Home in Acquisition of Home Care Now of Central Florida

Represented Enexia HBM LLC in Joint Venture Agreement

Served as legal counsel to Enexia HBM LLC, a pharmacy and health-related services company headquartered in New York, NY, in its joint venture agreement with Interchange RX, LLC, an Oklahoma-based hospice pharmacy benefits manager. 

Read More
Represented Enexia HBM LLC in Joint Venture Agreement

Represented Acentus in Acquisition by Henry Schein, Inc.

Served as legal counsel for Acentus, a national medical supplier specializing in the delivery of continuous glucose monitors for Medicare patients, in its acquisition by Henry Schein, Inc., a solutions company for health care professionals advising over 1 million customers globally to help improve operational success and clinical outcomes. The acquisition, which was announced on November 20, 2024, will see Henry Schein acquire substantially all of Acentus’ assets, and will expand its national homecare solutions platform to address the evolving needs of clients.

Read More
Represented Acentus in Acquisition by Henry Schein, Inc.


News


December 18, 2025

Business Transactions in Health Care Team Wins “Pharma & Devices Deal of the Year” at Global M&A Network’s 7th Annual USA Middle Markets M&A Atlas Awards Gala

Robinson+Cole’s Business Transactions in Health Care team won the “Pharma & Devices Deal of the Year” award presented by Global M&A Network at its the 7th Annual USA Middle Markets M&A Atlas Awards and 16th Annual Global M&A Atlas Awards Gala, on December 9, 2025, at the Metropolitan Club in New York City. The gala recognized accomplished leaders, dealmakers, outstanding firms, and the best-value creating transactions during 2025. The “Pharma & Devices Deal of the Year” award was presented for the successful sale of Acentus, a national medical supplier specializing in the delivery of continuous glucose monitors for Medicare patients, to Henry Schein, Inc., a solutions company for health care professionals advising over 1 million customers globally to improve operational success and clinical outcomes. Business Transactions in Health Care team co-chair Les Levinson led the complex deal, which saw Henry Schein acquire substantially all of Acentus’ assets, and expanded its national homecare solutions platform to address the evolving needs of its clients. The team was comprised of a cross-disciplinary group of R+C lawyers including, Kiernan Ignacio, Natale DiNatale, Nicole Diodati, Linn Freedman, Michael Kearney, Michael Lisitano, Virginia McGarrity, Kathryn Rattigan, Jacqueline Pennino Scheib, and Danielle Tangorre.

Global M&A Network
Business Transactions in Health Care Team Wins “Pharma & Devices Deal of the Year” at Global M&A Network’s 7th Annual USA Middle Markets M&A Atlas Awards Gala teaser
October 8, 2025

Robinson+Cole Healthcare Transactions Team Represents The Pennant Group in One of 2025’s Largest Homecare and Hospice Transactions

May 22, 2025

Health Care Transactions Team Represents Help at Home in Acquisition of Home Care Now of Central Florida

December 18, 2025

Business Transactions in Health Care Team Wins “Pharma & Devices Deal of the Year” at Global M&A Network’s 7th Annual USA Middle Markets M&A Atlas Awards Gala

Robinson+Cole’s Business Transactions in Health Care team won the “Pharma & Devices Deal of the Year” award presented by Global M&A Network at its the 7th Annual USA Middle Markets M&A Atlas Awards and 16th Annual Global M&A Atlas Awards Gala, on December 9, 2025, at the Metropolitan Club in New York City. The gala recognized accomplished leaders, dealmakers, outstanding firms, and the best-value creating transactions during 2025. The “Pharma & Devices Deal of the Year” award was presented for the successful sale of Acentus, a national medical supplier specializing in the delivery of continuous glucose monitors for Medicare patients, to Henry Schein, Inc., a solutions company for health care professionals advising over 1 million customers globally to improve operational success and clinical outcomes. Business Transactions in Health Care team co-chair Les Levinson led the complex deal, which saw Henry Schein acquire substantially all of Acentus’ assets, and expanded its national homecare solutions platform to address the evolving needs of its clients. The team was comprised of a cross-disciplinary group of R+C lawyers including, Kiernan Ignacio, Natale DiNatale, Nicole Diodati, Linn Freedman, Michael Kearney, Michael Lisitano, Virginia McGarrity, Kathryn Rattigan, Jacqueline Pennino Scheib, and Danielle Tangorre.

Global M&A Network
Business Transactions in Health Care Team Wins “Pharma & Devices Deal of the Year” at Global M&A Network’s 7th Annual USA Middle Markets M&A Atlas Awards Gala teaser
October 8, 2025

Robinson+Cole Healthcare Transactions Team Represents The Pennant Group in One of 2025’s Largest Homecare and Hospice Transactions

May 22, 2025

Health Care Transactions Team Represents Help at Home in Acquisition of Home Care Now of Central Florida

January 22, 2025

Robinson+Cole Represents Acentus in its Acquisition by Henry Schein, Inc.

January 6, 2025

Robinson+Cole Serves as Legal Counsel in one of the “Top 5 Home Health & Hospice Deals of 2024”

LevinPro HC
July 19, 2024

Robinson+Cole Represents Vast Medical Group in Investment by Sumitomo Corporation

July 18, 2024

Robinson+Cole Represents Signature Healthcare at Home’s Acquisition by the Pennant Group Inc.

April 30, 2024

Robinson+Cole Represents Gate Worldwide in Sale of Nomadix and GlobalReach to ASSA ABLOY

March 22, 2024

Robinson+Cole Represents EF Hutton as Sole Book-Running Manager in Black Hawk Acquisition Corp. IPO


January 22, 2025

Robinson+Cole Represents Acentus in its Acquisition by Henry Schein, Inc.

January 6, 2025

Robinson+Cole Serves as Legal Counsel in one of the “Top 5 Home Health & Hospice Deals of 2024”

LevinPro HC
July 19, 2024

Robinson+Cole Represents Vast Medical Group in Investment by Sumitomo Corporation

July 18, 2024

Robinson+Cole Represents Signature Healthcare at Home’s Acquisition by the Pennant Group Inc.

April 30, 2024

Robinson+Cole Represents Gate Worldwide in Sale of Nomadix and GlobalReach to ASSA ABLOY

March 22, 2024

Robinson+Cole Represents EF Hutton as Sole Book-Running Manager in Black Hawk Acquisition Corp. IPO


Publications


June 2022

Business Structure

SelectUSA’s 2022 Investor Guide

The Investor Guide is a first-step resource for companies interested in making business investments in the U.S. Each chapter is authored by highly-qualified professionals who regularly advise foreign investors. The Business Structure chapter offers an overview of common business structures for foreign investors. SelectUSA is the Department of Commerce program dedicated to facilitating and promoting high-impact business investment into the United States. View the chapter here.

June 17, 2020

Business Structure

SelectUSA’s June 2020 Investor Guide

SelectUSA is the Department of Commerce program dedicated to facilitating and promoting high-impact business investment into the United States and has published this Investor Guide as a first-step resource for companies interested in making business investments in the U.S. Each chapter is authored by highly qualified professionals who regularly advise foreign investors. The Business Structure chapter, authored by Anna, Jeff, Mike, and Michael, offers an overview of common business structures for foreign investors. Robinson+Cole has been representing international companies that wish to do business in the United States for decades. View article. 

Legal Update: Poison Pills, NOL Poison Pills and the COVID-19 Pandemic (COVID-19 Coronavirus) teaser
April 20, 2020

Legal Update: Poison Pills, NOL Poison Pills and the COVID-19 Pandemic (COVID-19 Coronavirus)

June 2022

Business Structure

SelectUSA’s 2022 Investor Guide

The Investor Guide is a first-step resource for companies interested in making business investments in the U.S. Each chapter is authored by highly-qualified professionals who regularly advise foreign investors. The Business Structure chapter offers an overview of common business structures for foreign investors. SelectUSA is the Department of Commerce program dedicated to facilitating and promoting high-impact business investment into the United States. View the chapter here.

June 17, 2020

Business Structure

SelectUSA’s June 2020 Investor Guide

SelectUSA is the Department of Commerce program dedicated to facilitating and promoting high-impact business investment into the United States and has published this Investor Guide as a first-step resource for companies interested in making business investments in the U.S. Each chapter is authored by highly qualified professionals who regularly advise foreign investors. The Business Structure chapter, authored by Anna, Jeff, Mike, and Michael, offers an overview of common business structures for foreign investors. Robinson+Cole has been representing international companies that wish to do business in the United States for decades. View article. 

Legal Update: Poison Pills, NOL Poison Pills and the COVID-19 Pandemic (COVID-19 Coronavirus) teaser
April 20, 2020

Legal Update: Poison Pills, NOL Poison Pills and the COVID-19 Pandemic (COVID-19 Coronavirus)

Legal Update: Deferring Capital Gains Taxes – Opportunity Zone Investments teaser
October 31, 2018

Legal Update: Deferring Capital Gains Taxes – Opportunity Zone Investments

April 12, 2010

Tax Changes Could Help Fuel M&A Boom

Buyouts


Legal Update: Deferring Capital Gains Taxes – Opportunity Zone Investments teaser
October 31, 2018

Legal Update: Deferring Capital Gains Taxes – Opportunity Zone Investments

April 12, 2010

Tax Changes Could Help Fuel M&A Boom

Buyouts

Events


Past

Tax Without Borders: Mobility, AI Structuring & the New U.S. Tax Order

Apr 30 2026
International Fiscal Association USA Westchester-Connecticut Region Event
Past

IRS Notice 2026-17 Modifications to Rules for Computing Taxable Income or Loss and Foreign Currency Gain or Loss Under Section 987

Apr 30 2026
International Fiscal Association USA Westchester-Connecticut Region Event
Past

Tax Without Borders: Mobility, AI Structuring & the New U.S. Tax Order

Apr 30 2026
International Fiscal Association USA Westchester-Connecticut Region Event
Past

IRS Notice 2026-17 Modifications to Rules for Computing Taxable Income or Loss and Foreign Currency Gain or Loss Under Section 987

Apr 30 2026
International Fiscal Association USA Westchester-Connecticut Region Event
Past

Tariffs and Taxes Under the New Administration

Feb 20 2025
International Fiscal Association Westchester NY/CT Region Event
Past

Qualified Small Business Stock

Sep 13 2022
Angel Investor Forum
Past

Investor Guide Webinar Mini-Series: An Overview of Common Business Structures

Aug 14 2020
SelectUSA
Past

Connecticut: The Land of Opportunity (Zones)

Mar 11 2020
From Soil to Solar: Land Law Development Forum
Past

Tariffs and Taxes Under the New Administration

Feb 20 2025
International Fiscal Association Westchester NY/CT Region Event
Past

Qualified Small Business Stock

Sep 13 2022
Angel Investor Forum
Past

Investor Guide Webinar Mini-Series: An Overview of Common Business Structures

Aug 14 2020
SelectUSA
Past

Connecticut: The Land of Opportunity (Zones)

Mar 11 2020
From Soil to Solar: Land Law Development Forum